Phase 3 Kidney Transplant Clinical Trials
13 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–13 of 13 trials
Recruiting
Phase 3
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
Kidney TransplantDelayed Graft FunctionDGF
Alexion Pharmaceuticals, Inc.450 enrolled130 locationsNCT06830798
Recruiting
Phase 2Phase 3
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
Kidney Transplant Rejection
Sanofi526 enrolled10 locationsNCT07412470
Recruiting
Phase 3
Shingrix in Renal Transplant Recipients
Kidney FailureKidney TransplantationKidney Failure, Chronic+2 more
University of Colorado, Denver132 enrolled4 locationsNCT04128189
Recruiting
Phase 3
A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
Kidney Transplant Failure and RejectionBK ViremiaKidney Transplant Infection
The University of Queensland280 enrolled12 locationsNCT05325008
Recruiting
Phase 3
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
Kidney Transplant; ComplicationsKidney DiseasesCytomegalovirus (CMV)
University of California, San Francisco360 enrolled5 locationsNCT06798909
Recruiting
Phase 3
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
Kidney TransplantType 1 Diabetes
Vertex Pharmaceuticals Incorporated10 enrolled7 locationsNCT06832410
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
End Stage Renal DiseaseDelayed Graft FunctionDeceased Donor Kidney Transplant
Apellis Pharmaceuticals, Inc.320 enrolled1 locationNCT07020832
Recruiting
Phase 3
Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients
Kidney Transplant Infection
University Hospital, Rouen144 enrolled1 locationNCT05708508
Recruiting
Phase 3
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
Cytomegalovirus InfectionsKidney Transplant InfectionPancreas Transplant
University of Wisconsin, Madison90 enrolled1 locationNCT06407232
Recruiting
Phase 3
The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.
Kidney Transplantation for More Than One YearPatients with a Kidney Transplantation on Cyclosporine
Central Hospital, Nancy, France36 enrolled1 locationNCT04450953
Recruiting
Phase 3
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
DeathAtrial FibrillationChronic Kidney Diseases+6 more
Region Stockholm1,400 enrolled34 locationsNCT05679024
Recruiting
Phase 3
Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Multicentre Randomized Non-inferiority Trial.
Kidney Transplant InfectionPyelonephritis Acute
Assistance Publique - Hôpitaux de Paris470 enrolled9 locationsNCT05597540
Recruiting
Phase 3
Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys
Kidney Transplant; ComplicationsIschemia Reperfusion InjuryDelayed Graft Function+1 more
Cliniques universitaires Saint-Luc- Université Catholique de Louvain60 enrolled1 locationNCT05430620